Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Formella AE"'
Autor:
Casillas-Espinosa PM; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.; Department of Neuroscience, School of Translational Medicine,, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia., Garcia-Olivares J; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Li R; Department of Neuroscience, School of Translational Medicine,, Monash University, Melbourne, Victoria, Australia., Li C; Department of Neuroscience, School of Translational Medicine,, Monash University, Melbourne, Victoria, Australia., Yu C; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Formella AE; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., O'Brien TJ; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.; Department of Neuroscience, School of Translational Medicine,, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia.
Publikováno v:
Epilepsia open [Epilepsia Open] 2024 Oct; Vol. 9 (5), pp. 1826-1836. Date of Electronic Publication: 2024 Aug 03.
Autor:
Espay AJ; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Cincinnati, OH, 45267, USA; Department of Neurology, University of Cincinnati, Cincinnati, OH, 45267, USA. Electronic address: alberto.espay@uc.edu., Ostrem JL; Movement Disorder and Neuromodulation Center, Department of Neurology, University of California San Francisco, San Francisco, CA, 94143, USA. Electronic address: Jill.Ostrem@ucsf.edu., Formella AE; Supernus Pharmaceuticals, Inc., Rockville, MD, 20850, USA. Electronic address: aformella@supernus.com., Tanner CM; Movement Disorder and Neuromodulation Center, Department of Neurology, University of California San Francisco, San Francisco, CA, 94143, USA. Electronic address: Caroline.Tanner@ucsf.edu.
Publikováno v:
Parkinsonism & related disorders [Parkinsonism Relat Disord] 2024 May; Vol. 122, pp. 106088. Date of Electronic Publication: 2024 Mar 04.
Autor:
Pahwa R; University of Kansas Medical Center, Kansas City, KS, United States., Fox S; Toronto Western Hospital, UHN and University of Toronto, Toronto, ON, Canada., Hauser RA; University of South Florida, Tampa, FL, United States., Isaacson S; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, United States., Lytle J; Formerly With Adamas Pharmaceuticals, Inc., Emeryville, CA, United States., Johnson R; Formerly With Adamas Pharmaceuticals, Inc., Emeryville, CA, United States., Llorens L; Formerly With Adamas Pharmaceuticals, Inc., Emeryville, CA, United States., Formella AE; Supernus Pharmaceuticals, Inc., Rockville, MD, United States., Tanner CM; University California San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Publikováno v:
Frontiers in neurology [Front Neurol] 2022 Oct 20; Vol. 13, pp. 846126. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022).
Autor:
Hauser RA; University of South Florida, Tampa, FL, USA. rhauser@usf.edu., Lytle J; Adamas Pharmaceuticals, Inc, Emeryville, CA, USA., Formella AE; Adamas Pharmaceuticals, Inc, Emeryville, CA, USA., Tanner CM; UC San Francisco, San Francisco, CA, USA.
Publikováno v:
NPJ Parkinson's disease [NPJ Parkinsons Dis] 2022 Mar 18; Vol. 8 (1), pp. 29. Date of Electronic Publication: 2022 Mar 18.
Autor:
Hauser RA; University of South Florida, Tampa, FL, USA., Goud S; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA., Formella AE; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.
Publikováno v:
Clinical parkinsonism & related disorders [Clin Park Relat Disord] 2021 Dec 08; Vol. 6, pp. 100123. Date of Electronic Publication: 2021 Dec 08 (Print Publication: 2022).
Autor:
Hauser RA; USF Parkinson's Disease and Movement Disorders Center, Parkinson Foundation Center of Excellence, University of South Florida, 4001 E. Fletcher Ave, 6th Floor, Tampa, FL, 33613, USA. rhauser@usf.edu., Mehta SH; Department of Neurology, Mayo Clinic-Scottsdale, Scottsdale, AZ, USA., Kremens D; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Chernick D; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA., Formella AE; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.
Publikováno v:
Neurology and therapy [Neurol Ther] 2021 Dec; Vol. 10 (2), pp. 739-751. Date of Electronic Publication: 2021 May 22.
Autor:
Hauser RA; Department of Neurology, University of South Florida, Tampa, FL, United States., Walsh RR; Muhammad Ali Parkinson Center at Barrow Neurological Institute, Phoenix, AZ, United States., Pahwa R; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States., Chernick D; Adamas Pharmaceuticals, Inc., Emeryville, CA, United States., Formella AE; Adamas Pharmaceuticals, Inc., Emeryville, CA, United States.
Publikováno v:
Frontiers in neurology [Front Neurol] 2021 Mar 26; Vol. 12, pp. 645706. Date of Electronic Publication: 2021 Mar 26 (Print Publication: 2021).
Autor:
Hammond FM; Indiana University School of Medicine, Rehabilitation Hospital of Indiana, 4141 Shore Drive, Indianapolis, IN 46254., Sauve W; TMS NeuroHealth Centers, Richmond, VA., Ledon F; Avanir Pharmaceuticals, Inc, Aliso Viejo, CA., Davis C; CSD Biostatistics, Inc, Tucson, AZ., Formella AE; Avanir Pharmaceuticals, Inc, Aliso Viejo, CA.
Publikováno v:
PM & R : the journal of injury, function, and rehabilitation [PM R] 2018 Oct; Vol. 10 (10), pp. 993-1003. Date of Electronic Publication: 2018 Feb 23.
Autor:
Zorowitz RD; MedStar National Rehabilitation Network, 102 Irving Street, NW, Washington, DC 20010. Electronic address: richard.zorowitz@medstar.net., Alexander DN; David Geffen School of Medicine at UCLA, Los Angeles, CA., Formella AE; Avanir Pharmaceuticals, Inc, Aliso Viejo, CA., Ledon F; Avanir Pharmaceuticals, Inc, Aliso Viejo, CA., Davis C; CSD Biostatistics, Inc, Tucson, AZ., Siffert J; Avanir Pharmaceuticals, Inc, Aliso Viejo, CA.
Publikováno v:
PM & R : the journal of injury, function, and rehabilitation [PM R] 2018 Jun 30. Date of Electronic Publication: 2018 Jun 30.
Autor:
Hammond FM; Physical Medicine and Rehabilitation, Indiana University School of Medicine, Rehabilitation Hospital of Indiana, 4141 Shore Drive, Indianapolis, IN, 46254, USA. Flora.hammond@rhin.com., Alexander DN; University of California, Los Angeles, CA, USA., Cutler AJ; Florida Clinical Research Center, LLC, Bradenton, FL, USA., D'Amico S; Cornerstone Medical Group, Franklin, TN, USA., Doody RS; Baylor College of Medicine, Houston, TX, USA., Sauve W; TMS NeuroHealth Centers, Richmond, VA, USA., Zorowitz RD; MedStar National Rehabilitation Network, Washington, DC, USA., Davis CS; CSD Biostatistics, Inc., Tucson, AZ, USA., Shin P; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA., Ledon F; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA., Yonan C; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA., Formella AE; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA., Siffert J; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Publikováno v:
BMC neurology [BMC Neurol] 2016 Sep 02; Vol. 16 (1), pp. 160. Date of Electronic Publication: 2016 Sep 02.